| UniProt ID | KCIP2_HUMAN | |
|---|---|---|
| UniProt AC | Q9NS61 | |
| Protein Name | Kv channel-interacting protein 2 | |
| Gene Name | KCNIP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 270 | |
| Subcellular Localization |
Isoform 1: Cell membrane Lipid-anchor . Detected on lipid rafts (By similarity). Isoform 2: Cell membrane Lipid-anchor . Isoform 6: Cell membrane Lipid-anchor . |
|
| Protein Description | Regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Modulates channel density, inactivation kinetics and rate of recovery from inactivation in a calcium-dependent and isoform-specific manner. In vitro, modulates KCND2/Kv4.2 and KCND3/Kv4.3 currents. Involved in KCND2 and KCND3 trafficking to the cell surface. May be required for the expression of I(To) currents in the heart (By similarity).. | |
| Protein Sequence | MRGQGRKESLSDSRDLDGSYDQLTGHPPGPTKKALKQRFLKLLPCCGPQALPSVSETLAAPASLRPHRPRLLDPDSVDDEFELSTVCHRPEGLEQLQEQTKFTRKELQVLYRGFKNECPSGIVNEENFKQIYSQFFPQGDSSTYATFLFNAFDTNHDGSVSFEDFVAGLSVILRGTVDDRLNWAFNLYDLNKDGCITKEEMLDIMKSIYDMMGKYTYPALREEAPREHVESFFQKMDRNKDGVVTIEEFIESCQKDENIMRSMQLFDNVI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 9 | Phosphorylation | RGQGRKESLSDSRDL CCCCCCCCCCCCCCC | 35.89 | - | |
| 19 | Phosphorylation | DSRDLDGSYDQLTGH CCCCCCCCHHHHCCC | 25.79 | 25307156 | |
| 20 (in isoform 9) | Phosphorylation | - | 17.15 | - | |
| 20 (in isoform 7) | Phosphorylation | - | 17.15 | - | |
| 20 (in isoform 5) | Phosphorylation | - | 17.15 | - | |
| 20 (in isoform 3) | Phosphorylation | - | 17.15 | - | |
| 20 | Phosphorylation | SRDLDGSYDQLTGHP CCCCCCCHHHHCCCC | 17.15 | 25332170 | |
| 24 | Phosphorylation | DGSYDQLTGHPPGPT CCCHHHHCCCCCCCC | 28.01 | - | |
| 31 | Phosphorylation | TGHPPGPTKKALKQR CCCCCCCCHHHHHHH | 51.60 | - | |
| 45 | S-palmitoylation | RFLKLLPCCGPQALP HHHHHHCCCCCCCCC | 4.17 | - | |
| 46 | S-palmitoylation | FLKLLPCCGPQALPS HHHHHCCCCCCCCCC | 9.34 | - | |
| 55 (in isoform 6) | Phosphorylation | - | 29.24 | 25159151 | |
| 103 | Phosphorylation | LQEQTKFTRKELQVL HHHHHCCCHHHHHHH | 42.24 | 18220336 | |
| 111 | Phosphorylation | RKELQVLYRGFKNEC HHHHHHHHHHHCCCC | 15.16 | 18220336 | |
| 207 | Phosphorylation | EMLDIMKSIYDMMGK HHHHHHHHHHHHHHH | 14.70 | 24719451 | |
| 209 | Phosphorylation | LDIMKSIYDMMGKYT HHHHHHHHHHHHHCC | 12.60 | - | |
| 216 | Phosphorylation | YDMMGKYTYPALREE HHHHHHCCHHHHHHH | 26.89 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KCIP2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KCIP2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KCIP2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KCND3_HUMAN | KCND3 | physical | 12928444 | |
| KCND2_HUMAN | KCND2 | physical | 20498229 | |
| KCNE4_HUMAN | KCNE4 | physical | 20498229 | |
| KCND2_HUMAN | KCND2 | physical | 10676964 | |
| KCIP2_HUMAN | KCNIP2 | physical | 15358149 | |
| KCIP1_HUMAN | KCNIP1 | physical | 26186194 | |
| AN13A_HUMAN | ANKRD13A | physical | 26186194 | |
| S10A7_HUMAN | S100A7 | physical | 26186194 | |
| KCIP1_HUMAN | KCNIP1 | physical | 28514442 | |
| S10A7_HUMAN | S100A7 | physical | 28514442 | |
| AN13A_HUMAN | ANKRD13A | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-103 AND TYR-111, ANDMASS SPECTROMETRY. | |